Research Assistant at the Protein Phase Transitions in Health and Disease Research Group (RA_BB)
Ref: RA_BB // Deadline: 26/01/2024
Ref: RA_BB // Deadline: 26/01/2024
Vaccinia in & as next-gen oncolytic virotherapy: exploiting the synergy between oncolysis and chemotherapy Dr Ernesto Mejías Pérez Ramón y Cajal researcher Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC), … Read more
3rd edition EMBL – IBEC Conference ENGINEERING MULTICELLULAR SYSTEMS EMBL and IBEC aim to contribute to the discussion on challenges and opportunities in the expanding field of engineered multicellular systems. Recent breakthroughs in stem … Read more
Ref: PD_ET // Deadline: 24/01/2024
Ref: PD-RJ/Deadline: 20/02/2024
This event will be held in Spanish El Nanodía Mundial Contra el Cáncer es un evento organizado en el marco del Día Mundial contra el Cáncer donde se darán a conocer las … Read more
The research, which was conducted on mice, demonstrates how these tiny nanomachines are propelled by urea present in urine and precisely target the tumour, attacking it with a radioisotope carried on their surface. Led by the IBEC and CIC biomaGUNE, the study opens the door to new, more efficient treatments for bladder cancer.
The BIST Forum has discussed how excellent science enhances the development of society and economic growth. The event was attended by the President of the Catalan Government, the Mayor of Barcelona, the heads of the highest economic institutions and the rectors of the main universities. At the event, the new BIST IGNITE projects for multidisciplinary research were announced, three of which have the participation of IBEC.
Ref: PD-SO/Deadline: 04/04/2024